The most revealing feature of vaccine licensure in 2026 is not a newly targeted pathogen. It is the concentration of innovation around familiar respiratory threats: seasonal influenza and COVID-19. Four notable...
Molecular clamping in vaccine development refers to a technology that uses a specially designed polypeptide (the “molecular clamp”) to stabilize viral proteins, particularly their pre-fusion conformations...
A study published by Gontu et al. offers a powerful proof-of-concept for a next-generation mRNA vaccine platform that combines dose efficiency, cross-variant protection, and modular design. If validated in clinical...